...
首页> 外文期刊>Ophthalmic plastic and reconstructive surgery >Sebaceous gland tumors of the eyelids and conjunctiva in the Muir-Torre syndrome: a clinicopathologic study of five cases and literature review.
【24h】

Sebaceous gland tumors of the eyelids and conjunctiva in the Muir-Torre syndrome: a clinicopathologic study of five cases and literature review.

机译:Muir-Torre综合征的眼睑和结膜皮脂腺肿瘤:5例临床病理研究并文献复习。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

PURPOSE: To study the sebaceous tumors of eyelid/conjunctiva associated with Muir-Torre syndrome (MTS) and to determine the role of immunohistochemical markers (MSH2, mismatch repair gene) in the diagnosis of patients with MTS. METHODS: A retrospective, noncomparative case series of 5 patients diagnosed with MTS from our laboratory. We also reviewed all previously reported cases of sebaceous eyelid tumors with a visceral malignancy. RESULTS: Four of the 5 patients were men, with a mean age of 55 years (range, 41 to 76 years). Four of the 5 patients had gastrointestinal carcinoma. On histopathological examination, 4 of the 5 tumors were classified as sebaceous adenomas that exhibited a distinct lobular pattern with prominent basaloid cells at the periphery of the lobules. One tumor was classified as a well-differentiated sebaceous gland adenocarcinoma. The diagnosis of MTS in all 5 patients was made after the diagnosis of the eyelid lesions. Immunohistochemical stains showed a lack of MSH2 expression intwo tumors, which is highly consistent with MTS. CONCLUSIONS: Muir-Torre syndrome should be considered in patients who develop sebaceous tumors of the ocular adnexa. Immunohistochemistry for MSH2 is a practical initial approach for screening MTS in patients with sebaceous tumors.
机译:目的:研究与Muir-Torre综合征(MTS)相关的眼睑/结膜皮脂瘤,并确定免疫组化标记物(MSH2,错配修复基因)在MTS患者诊断中的作用。方法:回顾性,非比较性病例系列,由我们实验室诊断为MTS的5例患者。我们还回顾了所有先前报道的内脏恶性皮脂腺眼皮瘤病例。结果:5名患者中有4名是男性,平均年龄为55岁(41至76岁)。 5名患者中有4名患有胃肠道癌。在组织病理学检查中,将5种肿瘤中的4种归类为皮脂腺瘤,其表现出明显的小叶模式,在小叶的周围具有突出的基底基底细胞。一种肿瘤被归类为高分化皮脂腺腺癌。所有5例患者的MTS均在眼睑病变诊断后做出。免疫组织化学染色显示在两个肿瘤中缺乏MSH2表达,这与MTS高度一致。结论:患有眼附件的皮脂瘤的患者应考虑Muir-Torre综合征。 MSH2的免疫组织化学是筛查皮脂瘤患者MTS的一种实用的初始方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号